Bold opportunities to change the course of mental health care.

Imogene Dunn, Ph.D., brings more than 25 years of experience in data science, including data management, biostatistics, and applications of information technology to the clinical development process. Prior to joining Vistagen, Dr. Dunn served at Vice President, Data Management, Data Sciences at Quantum Leap Healthcare Collaborative where she was responsible for leading biometrics and regulatory functions and providing strategic statistical expertise consistent with regulatory expectations for collaborative products. Dr. Dunn’s multidisciplinary management has included regulatory affairs, statistics, data management, and statistical programming. Dr. Dunn previously held positions at vTv Therapeutics (Nasdaq: VTVT); Otsuka Pharmaceutical Development and Commercialization, Inc. (TSE: 4578); PAREXEL International; Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN); YAMANOUCHI, Pharma America, Inc.(now Astellas Pharmaceuticals); and Pfizer, Inc. (NYSE: PFE). Dr. Dunn earned her Ph.D. in Biostatistics from the University of North Carolina at Chapel Hill.